J. Pharm. Pharmacogn. Res., vol. 14, no. 1, Article ID 2468, Jan-Feb 2026.
DOI: https://doi.org/10.56499/jppres_14.1.2468
Original Article
Effects of Kaempferia galanga L. extract on monosodium iodoacetate-induced osteoarthritis in rats
[Efectos del extracto de Kaempferia galanga L. sobre la osteoartritis inducida por yodoacetato monosódico en ratas]
Oktavia Rahayu Adianingsih1*, Wibi Riawan2, Aina Angelina3, Fifi Farida Fajrin1, Violita Ayu Puspita1, Surya Saputri1, Genera Dinan Adlina1, Akbar Saitama4, Eko Widaryanto4
1Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
2Department of Biochemistry and Molecular, Biochemistry Biomolecular Laboratory, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
3Department of Pathology Anatomy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
4Department of Agronomy, Faculty of Agriculture, Universitas Brawijaya, Malang, Indonesia.
*E-mail: oktavia.rahayu@ub.ac.id
Abstract
Context: Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive degradation of cartilage, synovial inflammation, and functional impairment. Kaempferia galanga L. extract (KGE) demonstrates analgesic, anti-inflammatory, and antioxidant properties, yet its effects on OA remain unclear.
Aims: To evaluate the chondroprotective and anti-inflammatory effects of KGE on a monosodium iodoacetate (MIA)-induced OA rat model.
Methods: Male Wistar rats were allocated into six groups: normal control, MIA control, MIA + KGE (90, 180, and 360 mg/kg), and MIA + ibuprofen (20 mg/kg). OA was induced via intra-articular MIA injection. Treatments were administered orally for 21 days. Knee joint diameter, plasma IL-1β, histopathology (OARSI scoring), and immunohistochemical markers (type II collagen, SOX-9, aggrecan, NF-κB, TNF-α, and MMP-13) were assessed.
Results: KGE reduced plasma IL-1β levels, suppressed NF-κB, TNF-α, and MMP-13, while concurrently enhancing type II collagen, SOX-9, and aggrecan in a dose-dependent manner. Administration of KGE at 360 mg/kg demonstrated the most pronounced chondroprotective effects.
Conclusions: KGE attenuated MIA-induced OA by modulating inflammatory pathways and preserving cartilage integrity, thereby supporting its potential as an alternative therapeutic option for osteoarthritis. Further research is warranted to elucidate its molecular mechanisms and assess its long-term safety profile.
Keywords: cartilage protection; inflammation; Kaempferia galanga; MIA model; OARSI; osteoarthritis.

Resumen
Contexto: La osteoartritis (OA) es una enfermedad articular degenerativa crónica que se caracteriza por la degradación progresiva del cartílago, la inflamación sinovial y el deterioro funcional. El extracto de Kaempferia galanga L. (KGE) presenta propiedades analgésicas, antiinflamatorias y antioxidantes; sin embargo, sus efectos sobre la OA aún no están claros.
Objetivos: Evaluar los efectos condroprotectores y antiinflamatorios del KGE en un modelo de rata con OA inducida por yodoacetato monosódico (MIA).
Métodos: Se asignaron ratas Wistar machos a seis grupos: control normal, control con MIA, MIA + KGE (90, 180 y 360 mg/kg) y MIA + ibuprofeno (20 mg/kg). La OA se indujo mediante inyección intraarticular de MIA. Los tratamientos se administraron por vía oral durante 21 días. Se evaluaron el diámetro de la articulación de la rodilla, la IL-1β plasmática, la histopatología (puntuación OARSI) y los marcadores inmunohistoquímicos (colágeno tipo II, SOX-9, agrecano, NF-κB, TNF-α y MMP-13).
Resultados: KGE redujo los niveles plasmáticos de IL-1β, suprimió NF-κB, TNF-α y MMP-13, y mejoró el colágeno tipo II, SOX-9 y el agrecano de forma dosis-dependiente. La administración de KGE a 360 mg/kg mostró los efectos condroprotectores más pronunciados.
Conclusiones: KGE atenuó la OA inducida por MIA mediante la modulación de las vías inflamatorias y la preservación de la integridad del cartílago, lo que respalda su potencial como opción terapéutica alternativa para la osteoartritis. Se requieren más investigaciones para dilucidar sus mecanismos moleculares y evaluar su perfil de seguridad a largo plazo.
Palabras Clave: inflamación; Kaempferia galanga; modelo de MIA; OARSI; osteoartritis; protección del cartílago.

Citation Format: Adianingsih OR, Riawan W, Angelina A, Fajrin FF, Puspita VA, Saputri S, Adlina GD, Saitama A, Widaryanto E (2026) Effects of Kaempferia galanga L. extract on monosodium iodoacetate-induced osteoarthritis in rats. J Pharm Pharmacogn Res 14(1): 2468. https://doi.org/10.56499/jppres_14.1.2468
References
Abo-Zalam HB, Abdel-Rahman RF, Abd-Ellah MF, Abdelsalam RM, Khattab MM (2021) In vivo investigation of the ameliorating effect of tempol against mia-induced knee osteoarthritis in rats: Involvement of TGF-β1/smad3/nox4 cue. Molecules 26(22): 6993. https://doi.org/10.3390/molecules26226993
Adianingsih OR, Ihsan BRP, Puspita OE, Maesayani KS (2023) Validation of high-performance liquid chromatography (HPLC) method for quantification of ethyl p-methoxycinnamate in Kaempferia galanga extract. Trop J Nat Prod Res 7(8): 3829–3835. https://doi.org/10.26538/tjnpr/v7i8.39
Central Bureau of Statistics (2018) Statistics of Medicinal Plants Indonesia. BPS-Statistics Indonesia.
Chen H, Tan XN, Hu S, Liu RQ, Peng LH, Li YM, Wu P (2021) Molecular mechanisms of chondrocyte proliferation and differentiation. Front Cell Dev Biol 9: 664168. https://doi.org/10.3389/fcell.2021.664168
Choi BR, Kang SJ, Kim JL, Lee YJ, Ku SK (2020) Effects of pomegranate concentrate powder: eucommiae cortex: achyranthis radix 5:4:1 (w/w) mixed formula on monosodium iodoacetate-induced osteoarthritis in rats. Nat Prod Commun 15(3): 1-18. https://doi.org/10.1177/1934578X20907725
Chun JM, Lee AY, Nam JY, Lim KS, Choe MS, Lee MY, Kim C, Kim JS (2021) Effects of Dipsacus asperoides extract on monosodium iodoacetate–induced osteoarthritis in rats based on gene expression profiling. Front Pharmacol 12: 615157. https://doi.org/10.3389/fphar.2021.615157
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H (2020) Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29: 100587. https://doi.org/10.1016/j.eclinm.2020.100587
Erten F, Ozdemir O, Tokmak M, Durmus AS, Ozercan IH, Morde A, Padigaru M, Sahin K (2024) Novel formulations ameliorate osteoarthritis in rats by inhibiting inflammation and oxidative stress. Food Sci Nutr 12(10): 7896–7912. https://doi.org/10.1002/fsn3.4407
Estakhri F, Panjehshahin MR, Tanideh N, Gheisari R, Mahmoodzadeh A, Azarpira N, Gholijani N (2020) The effect of kaempferol and apigenin on allogenic synovial membrane-derived stem cells therapy in knee osteoarthritic male rats. Knee 27(3): 817–832. https://doi.org/10.1016/j.knee.2020.03.005
Hall LW, Clarke KW, Trim CM (2001) Veterinary anaesthesia. London: W.B. Saunders.
Hamdalla HM, Ahmed RR, Galaly SR, Naguib IA, Alghamdi BS, Ahmed OM, Farghali A, Abdul-Hamid M (2022) Ameliorative effect of curcumin nanoparticles against monosodium iodoacetate-induced knee osteoarthritis in rats. Mediators Inflamm 2022: 8353472. https://doi.org/10.1155/2022/8353472
Heinegård D (2009) Proteoglycans and more - from molecules to biology. Int J Exp Pathol 90(6): 575–586. https://doi.org/10.1111/j.1365-2613.2009.00695.x
Indonesian Rheumatology Association (2014) Diagnosis and management of osteoarthritis. IRA.
Kanjanapothi D, Panthong A, Lertprasertsuke N, Taesotikul T, Rujjanawate C, Kaewpinit D, Sudthayakorn R, Choochote W, Chaithong U, Jitpakdi A, Pitasawat B (2004) Toxicity of crude rhizome extract of Kaempferia galanga L. (Proh Hom). J Ethnopharmacol 90(2–3): 359–365. https://doi.org/10.1016/j.jep.2003.10.020
Kim HL, Lee HJ, Lee DR, Choi BK, Yang SH (2020) Anti-osteoarthritic effects of Terminalia chebula fruit extract (Ayuflex®) in interleukin-1β-induced human chondrocytes and in rat models of monosodium iodoacetate (MIA)-induced osteoarthritis. Appl Sci 10(23): 8698. https://doi.org/10.3390/app10238698
Lallo S, Hardianti B, Sartini S, Ismail I, Laela D, Hayakawa Y (2022) Ethyl p-methoxycinnamate: an active anti-metastasis agent and chemosensitizer targeting NFκB from Kaempferia galanga for melanoma cells. Life 12: 337. https://doi.org/10.3390/life12030337
Leopoldino AO, MacHado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML (2019) Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev 2(2): CD013273. https://doi.org/10.1002/14651858.CD013273
Lepetsos P, Papavassiliou KA, Papavassiliou AG (2019) Redox and NF-κB signaling in osteoarthritis. Free Radic Biol Med 132: 90–100. https://doi.org/10.1016/j.freeradbiomed.2018.09.025
Lian C, Wang X, Qiu X, Wu Z, Gao B, Liu L, Liang G, Zhou H, Yang X, Peng Y, Liang A, Xu C, Huang D, Su P (2019) Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1−SMAD1 interaction. Bone Res 7: 8. https://doi.org/10.1038/s41413-019-0046-y
Lockwood SM, Lopes DM, McMahon SB, Dickenson AH (2019) Characterisation of peripheral and central components of the rat monoiodoacetate model of Osteoarthritis. Osteoarthr Cartil 27(4): 712–722. https://doi.org/10.1016/j.joca.2018.12.017
Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A (2022) Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol 74(7): 1172–1183. https://doi.org/10.1002/art.42089
Ma T, Zhang Z, Song X, Bai H, Li Y, Li X, Zhao J, Ma Y, Gao L (2018) Combined detection of COMP and CS846 biomarkers in experimental rat osteoarthritis: a potential approach for assessment and diagnosis of osteoarthritis. J Orthop Surg and Res 13(1): 230. https://doi.org/10.1186/s13018-018-0938-3
Mabey T, Honsawek S, Tanavalee A, Yuktanandana P, Wilairatana V, Poovorawan Y (2016) Plasma and synovial fluid inflammatory cytokine profiles in primary knee osteoarthritis. Biomarkers 21(7): 639–644. https://doi.org/10.3109/1354750X.2016.1171907
McDougall JJ, Muley MM, Philpott HT, Reid A, Krustev E (2017) Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor decreases end-stage osteoarthritis pain and peripheral neuropathy in mice. Arthritis Res Ther 19(1): 106. https://doi.org/10.1186/s13075-017-1313-1
Moilanen LJ, Hämäläinen M, Nummenmaa E, Ilmarinen P, Vuolteenaho K, Nieminen RM, Lehtimäki L, Moilanen E (2015) Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice - potential role of TRPA1 in osteoarthritis. Osteoarthr Cartil 23(11): 2017–2026. https://doi.org/10.1016/j.joca.2015.09.008
Molnar V, Matišić V, Kodvanj I, Bjelica R, Jeleč Ž, Hudetz D, Rod E, Čukelj F, Vrdoljak T, Vidović D, Starešinić M, Sabalić S, Dobričić B, Petrović T, Antičević D, Borić I, Košir R, Zmrzljak UP, Primorac D (2021) Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci 22(17): 9208. https://doi.org/10.3390/ijms22179208
Nepal M, Li L, Cho HK, Park JK, Soh Y (2013) Kaempferol induces chondrogenesis in ATDC5 cells through activation of ERK/BMP-2 signaling pathway. Food Chem Toxicol 62: 238–245. https://doi.org/10.1016/j.fct.2013.08.034
Nurani LH, Asahi A, Susanti H (2020) Determination of epms content and anti-inflammatory test rhizome extract Kaempferia galanga, L by inhibition of protein denaturation method. Pharmaciana 10(3): 381. https://doi.org/10.12928/pharmaciana.v10i3.15293
Ouyang Y, Wang W, Tu B, Zhu Y, Fan C, Li Y (2019) Overexpression of SOX9 alleviates the progression of human osteoarthritis in vitro and in vivo. Drug Des Devel Ther 13: 2833–2842. https://doi.org/10.2147/DDDT.S203974
Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell K, Salter D, van den Berg WB (2006) Osteoarthritis cartilage histopathology: Grading and staging. Osteoarthr Cartil 14(1): 13–29. https://doi.org/10.1016/j.joca.2005.07.014
Quintana L, Zur Nieden NI, Semino CE (2009) Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev 15(1): 29–41. https://doi.org/10.1089/ten.teb.2008.0329
Samodra G, Febrina D (2019) Anti-inflammatory effects of Kaempferia galanga L. rhizome extract in carrageenan-induced female rats. Adv Health Sci Res 20: 13–17. https://doi.org/10.2991/ahsr.k.200204.004
Song M, Choi YY, Jin SC, Baek HK, Yi S, Kim EJ, Yang WM (2025) FLEXA, a new herbal formulation, alleviates inflammation and cartilage degradation of osteoarthritis by inhibiting the activation of the MAPK/NF-κB signaling pathways. Fitoterapia 184: 106590. https://doi.org/10.1016/j.fitote.2025.106590
Srivastava N, Ranjana, Singh S, Gupta AC, Shanker K, Bawankule DU, Luqman S (2019) Aromatic ginger (Kaempferia galanga L.) extracts with ameliorative and protective potential as a functional food, beyond its flavor and nutritional benefits. Toxicol Rep 6: 521–528. https://doi.org/10.1016/j.toxrep.2019.05.014
Sun F, Zhang Y, Li Q (2017) Therapeutic mechanisms of ibuprofen, prednisone and betamethasone in osteoarthritis. Mol Med Rep 15(2): 981–987. https://doi.org/10.3892/mmr.2016.6068
Syahruddin AN, Dahlan CK, Taslim NA (2017) The effects of Kaempferia galanga L. extract on pain, stiffness and functional physic in patient with knee osteoarthritis: Double blind randomized clinical trial. Int J Sci Healthc Res 2(4): 37–43.
Tseng SH, Lee CJ, Chen SH, Chen CH, Tsai PW, Hsieh MS, Chu JS, Wang CC (2023) Cinnamic aldehyde, an anti-inflammatory component in Du-Huo-Ji-Sheng-Tang, ameliorates arthritis in II collagenase and monosodium iodoacetate induced osteoarthritis rat models. J Tradit Complement Med 13(1): 51–61. https://doi.org/10.1016/j.jtcme.2022.10.003
Umar MI, Asmawi MZ, Sadikun A, Atangwho IJ, Yam MF, Altaf R, Ahmed A (2012) Bioactivity-guided isolation of ethyl-p-methoxycinnamate, an anti-inflammatory constituent, from Kaempferia galanga L. extracts. Molecules 17(7): 8720–8734. https://doi.org/10.3390/molecules17078720
Umar MI, Asmawi MZ, Sadikun A, Majid AMSA, Al-Suede FSR, Hassan LEA, Altaf R, Ahamed MBK (2014) Ethyl-p-methoxycinnamate isolated from Kaempferia galanga inhibits inflammation by suppressing interleukin- 1, tumor necrosis factor-α, and angiogenesis by blocking endothelial functions. Clinics 69(2): 134–144. https://doi.org/10.6061/clinics/2014(02)10
Ushita M, Saito T, Ikeda T, Yano F, Higashikawa A, Ogata N, Chung U, Nakamura K, Kawaguchi H (2009) Transcriptional induction of SOX9 by NF-κB family member RelA in chondrogenic cells. Osteoarthr Cartil 17(8): 1065–1075. https://doi.org/10.1016/j.joca.2009.02.003
Wahyuni IS, Sufiawati I, Nittayananta W, Levita J (2022) Anti-inflammatory activity and wound healing effect of Kaempferia galanga L. rhizome on the chemical-induced oral mucosal ulcer in Wistar rats. J Inflamm Res 15: 2281–2294. https://doi.org/10.2147/JIR.S359042
Wang S-Y, Cai L, Yang N, Xu F-F, Wu Y-S, Liu B (2023) Chemical composition of the Kaempferia galanga L. essential oil and its in vitro and in vivo antioxidant activities. Front Nutr 10: 1080487. https://doi.org/10.3389/fnut.2023.1080487
Wang S, Yang J, Cai L, Li H, Han X, Liu B, Wu J (2025). Antioxidant effect of ethyl acetate fraction from Kaempferia galanga L.: integrated phytochemical profiling, network analysis, and experimental validation. Antioxidants 14(5): 551. https://doi.org/10.3390/antiox14050551
Yang J, Hu S, Bian Y, Yao J, Wang D, Liu X, Guo Z, Zhang S, Peng L (2022) Targeting cell death: pyroptosis, ferroptosis, apoptosis and necroptosis in osteoarthritis. Front Cell Devel Biol 9: 789948. https://doi.org/10.3389/fcell.2021.789948
© 2026 Journal of Pharmacy & Pharmacognosy Research